Cardiac resynchronisation in heart failure with right ventricular pacing

Поделиться
HTML-код
  • Опубликовано: 4 ноя 2023
  • The BUDAPEST CRT Upgrade trial marked the pioneering attempt to evaluate the efficacy and safety of a cardiac resynchronization therapy (CRT) upgrade in comparison to intracardiac defibrillator (ICD)-only treatment. This evaluation was conducted in patients with heart failure and reduced ejection fraction (HFrEF) who already had a pacemaker or ICD and experienced intermittent or permanent RV pacing.
    In this video, Dr. Chadi Alraies discusses with the principal investigator of the trial, Dr. Bela Merkely.
    Learn more about the interesting findings 👉cardiology-update.com
    #cardiology #cardiologist #cardiologyupdate #heartfailure #HFrEF #esccongress #esc2023

Комментарии •